rotaviru
worldwid
caus
sever
gastroenter
includ
sever
diarrhea
fatal
dehydr
infant
young
children
avail
vaccin
program
prevent
rotaviru
infect
limit
restrict
probiot
therapi
could
altern
method
antivir
prevent
modul
rotaviru
infect
studi
screen
antivir
activ
probiot
bacteria
lactobacillu
spp
bifidobacterium
spp
isol
young
korean
three
bacteria
lactobacillu
rumini
bifidobacterium
longum
inhibit
human
strain
wa
rotaviru
infect
cell
furthermor
bacteri
strain
inhibit
rotaviru
replic
rotavirusinfect
neonat
mous
model
clarifi
mechan
inhibit
investig
gene
express
interferon
ifn
signal
compon
ifninduc
antivir
effector
probiot
increas
level
compar
control
gene
express
ifnsign
compon
ifninduc
antivir
effector
also
increas
overal
result
indic
l
rumini
b
longum
effici
inhibit
rotaviru
replic
vitro
vivo
especi
antivir
effect
lactobacillu
rumini
worthi
notic
first
report
l
rumini
antivir
activ
antirotavir
effect
probiot
like
due
modul
immun
respons
promot
type
ifn
key
regul
ifn
signal
pathway
rotaviru
worldwid
caus
sever
gastroenter
infant
young
children
occur
rang
clinic
symptom
includ
sever
diarrhea
vomit
caus
fatal
dehydr
shock
death
symptom
normal
disappear
within
day
may
last
week
desselberg
et
al
antivir
therapi
current
avail
treatment
rotaviru
gastroenter
fluid
replac
zinc
administr
use
prevent
dehydr
treat
sever
diarrhea
chandran
et
al
one
prevent
rotaviru
vaccin
licens
mani
countri
use
routin
incid
rate
rotaviru
diseas
seem
similar
world
howev
mortal
rate
due
vaccin
fatal
rare
young
children
develop
countri
parashar
et
al
chen
et
al
rotaviru
vaccin
safe
effici
prevent
rotaviru
gastroenter
although
limit
vaccin
program
difficulti
distribut
cost
new
prevent
treatment
agent
modul
rotaviru
infecti
diseas
necessari
altern
method
antivir
agent
suggest
applic
probiot
bacteria
chai
et
al
kwak
et
al
lee
et
al
kim
et
al
lehtoranta
et
al
probiot
live
microorgan
administ
adequ
amount
confer
health
benefit
host
faowho
probiot
lactobacillu
spp
bifidobacterium
spp
report
multipl
potenti
health
benefit
includ
block
gastroenter
pathogen
enhanc
immun
respons
neutral
virus
rolf
minocha
zhang
et
al
preidi
et
al
sur
et
al
report
probiot
lactobacillu
rhamnosu
l
casei
bifidobacterium
bifidum
streptococcu
thermophilu
promot
innat
immun
respons
stimul
cellular
multipl
epitheli
cell
recent
research
report
probiot
effect
treatment
rotaviru
gastroenter
dubey
et
al
maragkoudaki
et
al
ventola
et
al
vlasova
et
al
studi
screen
antivir
activ
lactobacillu
spp
bifidobacterium
spp
isol
young
korean
probiot
evalu
antivir
activ
rotavirusinfect
cell
neonat
mous
model
continu
investig
probiot
suppress
rotaviru
infect
use
quantit
real
time
polymeras
chain
reaction
rtqpcr
human
colon
adenocarcinoma
cell
line
rhesu
monkey
kidney
cell
line
vero
obtain
korea
cell
line
bank
cell
grown
minimum
essenti
medium
mem
gibco
invitrogen
contain
fetal
bovin
serum
fb
gibco
invitrogen
uml
penicillin
uml
streptomycin
humidifi
co
incub
vero
cell
grown
roswel
park
memori
institut
medium
rpmi
gibco
invitrogen
contain
fb
uml
penicillin
uml
streptomycin
humidifi
co
incub
human
rotaviru
wa
strain
hrv
obtain
korea
bank
pathogen
virus
virus
propag
vero
cell
harvest
freezethaw
time
hrv
concentr
ultracentrifug
titer
determin
plaqu
form
unit
pfu
ml
plaqu
assay
vero
cell
viru
stock
store
use
hrv
activ
min
treatment
trypsin
two
probiot
bacteri
genera
use
lactobacillu
spp
bifidobacterium
spp
isol
young
korean
tabl
cultur
h
gener
anaerob
medium
gam
broth
nissui
pharm
anaerob
condit
prepar
probiot
bacteri
extract
cell
harvest
exponenti
growth
phase
centrifug
rpm
min
wash
phosphat
buffer
salin
pb
resuspend
buffer
bacteri
suspens
adjust
final
concentr
coloni
form
unit
cfu
ml
sonic
min
amplitud
cell
extract
use
experi
filtrat
balbc
dam
dayold
pup
obtain
koatech
hous
static
microisol
cage
special
rack
deliv
hepa
filter
air
cage
food
water
avail
ad
libitum
studi
approv
duksung
women
univers
institut
anim
care
use
committe
experi
perform
accord
guidelin
duksung
women
univers
polici
anim
care
use
mice
divid
randomli
five
group
neg
control
group
receiv
pb
three
test
group
receiv
respect
normal
group
mice
inocul
extract
wa
rotaviru
pfuml
via
oral
gavag
consecut
day
normal
control
group
segreg
anim
prevent
infect
weight
record
everi
day
sacrific
fecal
sampl
collect
mous
test
rotaviru
infect
use
diagnost
kit
sd
viru
detect
three
probiot
extract
cfuml
administ
oral
day
anim
sacrif
fece
care
remov
colon
rectum
gastrointestin
tract
collect
weigh
specimen
rins
twice
steril
pb
store
cytotox
probiot
bacteri
strain
cultur
cell
assess
use
mtt
bromid
sigma
assay
vero
cell
seed
plate
densiti
cellswel
vv
extract
lactobacillu
spp
bifidobacterium
spp
incub
h
cell
media
alon
use
control
group
incub
medium
remov
mtt
solut
ad
well
incub
h
mtt
solut
remov
dimethyl
sulfoxid
dmso
ad
well
viabl
cell
detect
measur
absorb
nm
vero
cell
cultur
sixwel
plate
cell
inocul
trypsinactiv
hrv
pfuml
vv
extract
lactobacillu
spp
bifidobacterium
spp
h
inoculum
remov
cell
wash
pb
cell
cover
ml
overlay
media
consist
agaros
fb
rpmi
media
overlay
media
harden
cell
incub
h
co
overlay
media
remov
cell
stain
crystal
violet
observ
plaqu
format
select
probiot
bacteria
base
result
plaqu
assay
vero
cell
three
select
probiot
bacteria
use
plaqu
assay
cell
describ
total
cellular
rna
extract
hrvinfect
cell
use
qiaamp
viral
rna
mini
kit
rneasi
mini
kit
qiagen
accord
manufactur
instruct
intestin
tissu
homogen
use
tissu
homogen
total
rna
isol
tissu
use
rneasi
mini
kit
qiagen
revers
transcrib
cdna
omniscript
revers
transcript
kit
qiagen
accord
manufactur
instruct
cdna
use
templat
realtim
pcr
realtim
pcr
reaction
mixtur
carri
reaction
mixtur
consist
master
mix
primer
cdna
templat
steril
water
master
mix
prepar
use
power
master
sybr
green
pcr
master
mix
appli
biosystem
human
pcr
primer
rota
sens
ggctttaaaagagagaatttccg
antisens
ggtcacatcatacaattcta
gapdh
sens
ccatcaccatcttcc
antisens
murin
pcr
primer
sens
cctgt
antisens
tcactcctcc
sens
atgaacaacaggt
antisens
aggagctcctgacatt
ifnr
sens
catgtgtgcttcccacc
antisens
cellml
simultan
infect
rotaviru
treat
extract
probiot
bacteria
cfuml
vv
h
antivir
activ
determin
plaqu
assay
repeat
independ
experi
least
five
time
highest
lowest
valu
exclud
valu
shown
repres
mean
sd
signific
differ
p
p
cell
cellml
simultan
infect
rotaviru
treat
extract
probiot
bacteria
cfuml
vv
h
antivir
activ
determin
plaqu
assay
repeat
independ
experi
least
five
time
highest
lowest
valu
exclud
valu
shown
repres
mean
sd
signific
differ
p
p
sens
antisens
oa
sens
antisens
sens
antisens
act
pkr
sens
gcaccg
antisens
ggagcacgaag
gapdh
sens
acggccgcatct
antisens
acggccaaatccgttc
realtim
quantit
pcr
conduct
appli
biosystem
step
one
plu
tm
realtim
pcr
system
appli
biosystem
gapdh
housekeep
gene
use
intern
control
repeat
independ
experi
least
five
time
highest
lowest
valu
exclud
rel
quantif
target
gene
calcul
use
ddct
method
livak
schmittgen
valu
express
mean
standard
deviat
sd
statist
signific
assess
p
comparison
statist
analysi
perform
statist
product
servic
solut
spss
statist
softwar
use
mtt
assay
investig
cytotox
probiot
bacteria
strain
vero
cell
cell
viabil
treatment
probiot
extract
show
compar
control
group
tabl
initi
lactobacillu
spp
bifidobacterium
spp
isol
young
korean
use
perform
plaqu
assay
vero
cell
select
probiot
strain
highest
inhibitori
effect
three
strain
suppress
wa
rotaviru
infect
vero
cell
compar
control
fig
lactobacillu
rumini
spm
cell
cellml
infect
rotaviru
h
follow
treatment
extract
probiot
bacteria
cfuml
vv
h
repeat
independ
experi
least
five
time
highest
lowest
valu
exclud
valu
shown
repres
mean
sd
signific
differ
p
p
inhibit
rotaviru
infect
bifidobacterium
longum
reduc
plaqu
format
respect
base
result
select
probiot
bacteria
carri
plaqu
assay
b
longum
l
rumini
cell
describ
use
either
cfuml
cfuml
strain
demonstr
signific
antivir
activ
hrvinfect
cell
fig
similar
result
vero
cell
l
rumini
treatment
significantli
decreas
plaqu
format
cfuml
drop
plaqu
cell
compar
control
cfuml
decreas
plaqu
format
indic
dosedepend
reduc
plaqu
format
cell
b
longum
show
similar
result
determin
whether
probiot
antivir
activ
inhibit
rotaviru
replic
evalu
rotaviru
rna
express
rotavirusinfect
cell
rtqpcr
rotaviru
gene
express
reflect
similar
result
cell
treat
probiot
cfuml
rotaviru
infect
fig
decreas
rotaviru
gene
express
drop
gene
express
respect
compar
control
group
observ
treatment
significantli
inhibit
rotaviru
gene
express
hrvinfect
cell
thu
investig
anti
viral
effect
probiot
use
rotavirusinfect
neonat
mous
model
observ
bodi
weight
neonat
mice
rotaviru
infect
fig
control
group
lost
weight
day
wherea
normal
group
steadili
increas
weight
result
agreement
incub
period
rotaviru
group
weight
mice
reduc
compar
normal
group
incub
period
rotaviru
administr
cfuml
rotavirusinfect
neonat
mice
weight
group
gradual
increas
compar
control
group
assess
potenti
antivir
activ
probiot
evalu
rotaviru
gene
express
rotavirusinfect
neonat
mous
model
significantli
inhibit
rotaviru
gene
express
hrvinfect
neonat
mice
similar
vitro
result
fig
found
group
decreas
rotaviru
gene
express
compar
control
group
reduc
rotaviru
gene
express
respect
group
increas
antivir
activ
compar
result
vitro
confirm
inhibit
rotaviru
replic
neonat
mous
model
examin
whether
probiot
inhibit
rotaviru
infect
type
ifn
signal
pathway
wa
rotavirusinfect
neonat
mice
rtqpcr
observ
significantli
increas
gene
express
rotaviru
infect
neonat
mice
fig
gene
express
increas
doubl
control
group
treat
group
treat
hrvinfect
mice
express
significantli
increas
express
unaffect
measur
ifn
receptor
signal
transduc
activ
transcript
stat
gene
express
stimul
type
ifn
fig
probiot
significantli
increas
level
ifn
receptor
gene
express
show
outstand
result
investig
gene
express
three
ifninduc
antivir
effector
myxoviru
resist
mxa
synthetas
oa
protein
kinas
r
pkr
fig
mxa
oa
gene
express
increas
treatment
probiot
pkr
express
increas
influenc
administr
probiot
effect
altern
treatment
moder
rotaviru
gastroenter
bacteriotherapi
recent
guandalini
foy
et
al
report
probiot
bacteriotherapi
increasingli
recogn
moder
infecti
diarrhea
mechan
improv
intestin
homeostasi
accord
ventola
et
al
l
rhamnosu
gg
may
increas
rotaviru
clearanc
bodi
reduc
colon
swell
vlasova
et
al
report
l
rhamnosu
gg
b
lacti
moder
rotavirusassoci
diarrhea
neonat
gnotobiot
pig
number
pediatr
clinic
trial
report
l
acidophilu
l
paracasei
l
rhamnosu
gg
l
reuteri
thermophilu
probiot
mixtur
signific
effect
treatment
diarrhea
children
guandalini
et
al
sarker
et
al
dubey
misra
et
al
studi
clearli
show
probiot
metabolit
good
altern
low
cost
prevent
treatment
agent
studi
screen
antivir
effect
lactobacillu
spp
bifidobacterium
spp
isol
young
korean
wa
rotaviru
infect
vero
cell
select
probiot
bacteria
lactobacillu
rumini
bifidobacterium
longum
show
highest
inhibitori
effect
wa
rotaviru
base
result
plaqu
assay
rotavirusinfect
vero
cell
probiot
show
signific
antivir
activ
wa
rotaviru
infect
cell
decreas
plaqu
format
compar
control
group
also
inhibit
respect
accord
et
al
probiot
could
block
viral
attach
surfac
intestin
cell
competit
inhibit
entri
howev
result
confirm
whether
probiot
inhibit
rotaviru
replic
modul
viral
cycl
therefor
evalu
rotaviru
rna
express
treat
wainfect
cell
probiot
probiot
demonstr
antivir
activ
inhibit
rotaviru
replic
show
benefici
effect
inhibit
rotaviru
infect
drop
gene
express
respect
compar
control
group
taken
togeth
result
reveal
inhibit
wa
rotaviru
replic
infect
investig
antivir
effect
probiot
rotaviru
use
rotavirusinfect
neonat
mous
model
control
group
infect
rotaviru
lost
weight
fourth
day
administr
rotaviru
wherea
normal
group
steadili
increas
weight
administr
group
rate
weight
gain
gradual
increas
without
weight
loss
although
group
lost
weight
fifth
day
rate
weight
loss
small
durat
short
compar
control
evalu
rotaviru
gene
express
confirm
antivir
activ
probiot
group
decreas
rotaviru
gene
express
compar
control
group
reduc
rotaviru
gene
express
respect
similarli
antivir
activ
inhibit
rotaviru
replic
vitro
vivo
result
indic
probiot
might
inhibit
rotaviru
infect
reduc
symptom
durat
rotaviru
induc
inflamm
activ
cytokin
respons
intestin
epitheli
cell
rollo
et
al
interferon
repres
cytokin
activ
inflamm
type
ifn
includ
key
compon
host
defens
viral
infect
possess
power
antivir
properti
randal
goodbourn
releas
virusinfect
cell
bind
specif
ifn
receptor
lead
activ
jakstat
signal
pathway
activ
induc
ifnmedi
antivir
respons
effector
pathway
mx
gtpase
pathway
ribonucleas
l
pathway
pkr
pathway
effector
pathway
individu
block
viral
transcript
degrad
viral
rna
inhibit
translat
modifi
protein
function
control
step
viral
replic
sadler
william
recent
report
sever
rotaviru
strain
suppress
ifn
product
rotavirusinfect
cell
pott
et
al
angel
et
al
shen
et
al
ifn
use
antirotaviru
agent
feng
et
al
pott
et
al
similarli
park
et
al
report
l
plantarum
exhibit
antivir
effect
influenza
viru
infect
modul
innat
immun
lee
et
al
report
b
adolescenti
inhibit
hepat
b
viru
ifnmedi
antivir
respons
mention
probiot
abil
moder
immun
respons
antivir
activ
activ
variou
cytokin
clarifi
mechan
antivir
effect
novel
probiot
assess
whether
l
rumini
b
longum
inhibit
rotaviru
infect
ifnmedi
antivir
respons
result
gene
express
similar
result
previou
studi
park
et
al
probiot
significantli
increas
level
found
ifnsign
compon
also
significantli
upregul
probiot
besid
treatment
increas
gene
express
ifninduc
antivir
effector
result
indic
novel
probiot
modul
immun
respons
promot
type
ifn
key
regul
ifn
signal
pathway
interestingli
antivir
activ
probiot
congruou
gene
express
ifninduc
antivir
effector
reason
result
predict
rotaviru
suppress
immun
respons
variou
mechan
infect
period
data
indic
novel
probiot
antivir
activ
modul
ifnmedi
innat
immun
rotaviru
infect
especi
worth
note
lactobacillu
rumini
antivir
effect
rotaviru
l
rumini
known
autochthon
speci
gastrointestin
tract
human
mammal
l
rumini
exist
variou
speci
lack
research
biolog
activ
rel
lactobacilli
taweechotipatr
et
al
nevil
et
al
demonstr
l
rumini
exhibit
immunomodulatori
properti
previous
report
antimicrobi
activ
l
rumini
isol
healthi
korean
yun
et
al
lee
et
al
recent
research
isol
l
rumini
strain
variou
speci
report
charact
ford
et
al
et
al
odonnel
et
al
howev
report
antivir
activ
l
rumini
first
report
concern
antivir
activ
l
rumini
overal
result
indic
l
rumini
b
longum
effici
inhibit
rotaviru
replic
wa
rotavirusinfect
cell
infect
neonat
mous
model
antivir
effect
three
probiot
like
due
modul
immun
respons
promot
type
ifn
key
regul
ifn
signal
pathway
especi
antivir
effect
l
rumini
worthi
notic
first
report
l
rumini
antivir
activ
data
suggest
b
longum
l
rumini
potenti
new
prevent
reliev
tool
rotaviru
gastroenter
